Sabby Management’s PAVmed PAVM Stock Holding History

Sabby Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,109	Closed	-$1.33M	–	144
2018 Q2	$1.33M	Buy	3,109 +1,089	+54%	+$666K	0.21%	52
2018 Q1	$1.49M	Buy	+2,020	New	+$1.73M	0.18%	49

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management's PAVM Position: Q3 2018 in Review

Sabby Management sold out of PAVmed (PAVM) in Q3 2018, closing a stake of 3,109 shares — an estimated $1.33M sold.

Sabby Management first reported a position in PAVM in Q1 2018 and held it in 2 quarters. The position peaked at $1.49M in Q1 2018. 14 funds tracked by Wall St. Rank hold PAVM as of Q3 2018.

Sabby Management reported no remaining PAVmed position as of Q3 2018 after selling out during the quarter.
Sabby Management sold 3,109 PAVmed shares in Q3 2018, an estimated $1.33M.
Sabby Management first reported a position in PAVmed in Q1 2018 and held it in 2 quarters.
Sabby Management's PAVmed position peaked at $1.49M in Q1 2018.
14 funds tracked by Wall St. Rank held PAVmed as of Q3 2018.

Based on Sabby Management's 13F filing for Q3 2018, filed 14 Nov 2018.